The In Vitro Shuttle LNP transfection kit series is developed based on Hanz Biotech’s proprietary lipid nanoparticle (LNP) technology, offering a high-efficiency, low-toxicity solution for nucleic acid delivery in cell lines. The series includes two versions: the In Vitro Shuttle LNP Cell Transfection Kit and the In Vitro Shuttle LNP Gene Editing Kit.

The Cell Transfection Kit is suitable for delivering mRNA, siRNA, and other nucleic acids into commonly used cell lines such as HEK293, HeLa, and 293T. The Gene Editing Kit is specifically optimized for CRISPR/Cas9 systems (Cas9 mRNA + gRNA), significantly enhancing gene editing efficiency.

These kits combine high transfection performance with minimal cytotoxicity, maintaining cell viability and proliferation. They are broadly compatible with both suspension and adherent cells and require no specialized equipment, enabling simple and effective delivery.

With excellent reproducibility and stability, the In Vitro Shuttle LNP kits provide reliable support for a wide range of applications, including cell biology research, gene function studies, gene editing, and drug screening.